ROCURONIUM BROMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Rocuronium Bromide patents expire, and what generic alternatives are available?
Rocuronium Bromide is a drug marketed by Caplin, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Meitheal, Mylan Institutional, Norvium Bioscience, Piramal Critical, Prinston Inc, Sagent Pharms Inc, Sandoz, Shandong, Steriscience, Tamarang, Teva Pharms, and West Ward Pharm Corp. and is included in eighteen NDAs.
The generic ingredient in ROCURONIUM BROMIDE is rocuronium bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rocuronium Bromide
A generic version of ROCURONIUM BROMIDE was approved as rocuronium bromide by HOSPIRA on November 26th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROCURONIUM BROMIDE?
- What are the global sales for ROCURONIUM BROMIDE?
- What is Average Wholesale Price for ROCURONIUM BROMIDE?
Summary for ROCURONIUM BROMIDE
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 18 |
| Finished Product Suppliers / Packagers: | 22 |
| Raw Ingredient (Bulk) Api Vendors: | 75 |
| Clinical Trials: | 57 |
| Patent Applications: | 543 |
| DailyMed Link: | ROCURONIUM BROMIDE at DailyMed |
Recent Clinical Trials for ROCURONIUM BROMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chosun University Hospital | N/A |
| Assiut University | Phase 2/Phase 3 |
| Yangzhou University | N/A |
Pharmacology for ROCURONIUM BROMIDE
| Drug Class | Nondepolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for ROCURONIUM BROMIDE
US Patents and Regulatory Information for ROCURONIUM BROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 078717-002 | Nov 26, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Steriscience | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 217092-001 | Jul 22, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| West Ward Pharm Corp | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 204679-001 | Feb 28, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Tamarang | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 091115-001 | Aug 27, 2012 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Caplin | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 216234-001 | Mar 2, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
